[1] 喻芳明,陈亚侠,聂桂兰,等. 宫颈癌患者盆腔淋巴结转移高危因素分析[J]. 浙江预防医学,2015,27(10):995-998. [2] JOHNSTON E I,LOGANI S.Cytologic diagnosis of atypical squamous cells of undetermined significance in perimenopausal and postmenopausal women:lessons learned from human Papillomavirus DNA testing[J]. Cancer,2007,111(3):160-165. [3] ZUR HAUSEN H.Papillomaviruses and cancer:from basic studies to clinical application[J]. Nat Rev Cancer,2002,2(5):342-350. [4] LIANG H,FU M,ZHOU J,et al.Evaluation of 3D-CPA,HR-HPV,and TCT joint detection on cervical disease screening[J]. Oncol Lett,2016,12(2):887-892. [5] 曹泽毅. 中华妇产科学[M]. 3版. 北京:人民卫生出版社,2014:2103-2106. [6] WHO.Cervical cancer control a guideline to essential practice[M].Switzerland World Health Organition,2006:79-125. [7] 沈芳玲,殷玉明,夏敏娟,等. 海宁市宫颈癌筛查高风险人群评估及流行病学调查[J]. 中国计划生育学杂志,2015,23(9):595-599. [8] 黄紫艳,陈颖. 4 498名体检妇女高危型人乳头瘤病毒感染状况调查[J]. 浙江预防医学,2014,26(6):613-614,617. [9] 陈秋梅,汪皓,郭恒,等. 深圳某社区非户籍女性HPV感染与宫颈鳞状上皮内病变的相关性研究[J]. 海南医学,2017,28(5):720-723. [10] HUIJSMANS C J,GEURTS-GIELE W R,LEEIJEN C,et al. HPV prevalence in the Dutch cervical cancer screening population (DuSC study):HPV testing using automated HC2,cobas and Aptima workflows[J]. BMC Cancer,2016,16(1):922. [11] 王智宇,包生武,张洪炜,等. 13 909例银川市乡镇农村妇女宫颈癌筛查结果分析[J]. 宁夏医科大学学报,2016,38(11):1319-1320. [12] 王静娴,文静,肖静,等. 东莞市大岭山镇4 402例宫颈癌筛查分析[J]. 广州医科大学学报,2015(4):106-108. [13] 徐艺,杨静秀,王玉平. HC2-HPV 检测法联合液基细胞学在宫颈癌及癌前病变筛查中的临床意义[J]. 实用癌症杂志,2016,31(6): 1006-1008. [14] 唐努尔·阿不力米提,帕提曼·米吉提,古里给娜·阿布都热西提. TCT和HC2-HPV-DNA宫颈癌筛查法在临床的应用效果比较[J]. 癌症进展,2016,14(8):802-804. |